MFC Stock Analysis: Manulife Financial | NYSE
Insurance - Life | NYSE, USA | Market Cap: 71.724m USD | 12M Return: 45.6% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 57.8M
EPS Trend: 8.0%
Qual. Beats: 0
Rev. Trend: 4.9%
Qual. Beats: 0
Warnings
No concerns identified
Tailwinds
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Manulife Financial Corporation is a Canadian-based diversified financial services provider operating across the United States, Canada, Asia, and other international markets. It is classified within the Life & Health Insurance sub-industry of the Financials sector and reports through three business segments: Wealth and Asset Management Businesses, Insurance and Annuity Products, and Corporate and Other.
The Wealth and Asset Management segment serves retirement, retail, and institutional clients through affiliated agents and brokers, independent securities firms, financial advisors, pension consultants, and banks. The Insurance and Annuity Products segment offers individual life insurance, long-term care insurance, annuities, and deposit and credit products, distributed via insurance agents, brokers, banks, financial planners, and direct marketing. Life insurers typically allocate premiums across long-duration and alternative assets to match the timing and inflation sensitivity of their policyholder obligations.
The Corporate and Other segment includes property and casualty reinsurance, run-off reinsurance operations (variable annuities and accident and health), and the companys timberland and agricultural portfolios-an alternative-asset class insurers use to diversify returns and back long-dated liabilities. Manulife also engages in investment counseling, mutual fund and portfolio management, insurance agency, broker-dealer, fund management, and integrated banking services. The company was incorporated in 1887 and is headquartered in Toronto, Canada.
- Asia wealth and asset management segment expands double digits
- Interest rate cuts pressure life insurance investment spreads
- Long-term care and variable annuity reserves remain key risk
| Net Income: 6.42b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA -0.09 > 1.0 |
| NWC/Revenue: 62.74% < 20% (prev -837.0%; Δ 899.7% < -1%) |
| CFO/TA 0.03 > 3% & CFO 29.0b > Net Income 6.42b |
| Net Debt (-21.2b) to EBITDA (10.3b): -2.06 < 3 |
| Current Ratio: 2.24 > 1.5 & < 3 |
| Outstanding Shares: last quarter (1.71b) vs 12m ago -1.21% < -2% |
| Gross Margin: 50.23% > 18% (prev 77.80%; Δ -27.57% > 0.5%) |
| Asset Turnover: 7.90% > 50% (prev 4.72%; Δ 3.18% > 0%) |
| Interest Coverage Ratio: 6.10 > 6 (EBIT TTM 9.41b / Interest Expense TTM 1.54b) |
| A: 0.05 (Total Current Assets 89.9b - Total Current Liabilities 40.2b) / Total Assets 1027b |
| B: 0.00 (Retained Earnings 5.03b / Total Assets 1027b) |
| C: 0.01 (EBIT TTM 9.41b / Avg Total Assets 1004b) |
| D: 0.05 (Book Value of Equity 51.5b / Total Liabilities 973b) |
| Altman-Z'' = 0.45 = B |
| DSRI: 3.0 (Receivables 55.3b/2.51b, Revenue 79.3b/46.3b) |
| GMI: 1.55 (GM 77.80% / 50.23%) |
| AQI: 0.94 (AQ_t 0.91 / AQ_t-1 0.97) |
| SGI: 1.71 (Revenue 79.3b / 46.3b) |
| TATA: -0.02 (NI 6.42b - CFO 29.0b) / TA 1027b) |
| Beneish M = -0.41 (Cap -4..+1) = D |
As of July 28, 2026, the stock is trading at USD 44.06 with a total of 1,362,049 shares traded. Over the past week, the price has changed by +3.67%, over one month by +8.31%, over three months by +15.26% and over the past year by +45.56%.
Current recommended Stop Loss: 43.10 (which is 2.2% or 1.4 ATR below the current price).
Manulife Financial has received a consensus analysts rating of 3.77. Therefore, it is recommended to hold MFC.
- StrongBuy: 3
- Buy: 5
- Hold: 4
- Sell: 1
- StrongSell: 0
| Analysts Target Price | 35.6 | -19.2% |
Market Cap CAD = 101b (71.7b USD * 1.4075 USD.CAD)
P/E Trailing = 17.4332
P/E Forward = 13.4953
P/S = 2.2393
P/B = 2.2446
P/EG = 0.7785
Revenue TTM = 79.3b CAD
EBIT TTM = 9.41b CAD
EBITDA TTM = 10.3b CAD
Long Term Debt = 13.1b CAD (from longTermDebt, last quarter)
Short Term Debt = 377.0m CAD (from shortTermDebt, last quarter)
Debt = 13.4b CAD (from shortLongTermDebtTotal, last quarter)
Net Debt = -21.2b CAD (calculated: Debt 13.4b - CCE 34.6b)
Enterprise Value = 79.8b CAD (101b + Debt 13.4b - CCE 34.6b)
Interest Coverage Ratio = 6.10 (Ebit TTM 9.41b / Interest Expense TTM 1.54b)
EV/FCF = 2.75x (Enterprise Value 79.8b / FCF TTM 29.0b)
FCF Yield = 36.31% (FCF TTM 29.0b / Enterprise Value 79.8b)
FCF Margin = 36.49% (FCF TTM 29.0b / Revenue TTM 79.3b)
Net Margin = 8.09% (Net Income TTM 6.42b / Revenue TTM 79.3b)
Gross Margin = 50.23% ((Revenue TTM 79.3b - Cost of Revenue TTM 39.5b) / Revenue TTM)
Gross Margin QoQ = none% (prev 76.01%)
Tobins Q-Ratio = 0.08 (Enterprise Value 79.8b / Total Assets 1027b)
Interest Expense / Debt = 11.47% (Interest Expense 1.54b / Debt 13.4b)
Taxrate = 15.11% (1.19b / 7.86b)
NOPAT = 7.98b (EBIT 9.41b * (1 - 15.11%))
Current Ratio = 2.24 (Total Current Assets 89.9b / Total Current Liabilities 40.2b)
Debt / Equity = 0.26 (Debt 13.4b / totalStockholderEquity, last quarter 51.5b)
Debt / EBITDA = -2.06 (Net Debt -21.2b / EBITDA 10.3b)
Debt / FCF = -0.73 (Net Debt -21.2b / FCF TTM 29.0b)
Total Stockholder Equity = 50.9b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.64% (Net Income 6.42b / Total Assets 1027b)
RoE = 12.61% (Net Income TTM 6.42b / Total Stockholder Equity 50.9b)
RoCE = 14.69% (EBIT 9.41b / Capital Employed (Equity 50.9b + L.T.Debt 13.1b))
RoIC = 0.81% (NOPAT 7.98b / Invested Capital 983b)
WACC = 9.03% (E(101b)/V(114b) * Re(8.94%) + D(13.4b)/V(114b) * Rd(11.47%) * (1-Tc(0.15)))
Discount Rate = 8.94% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -93.60 | Cagr: -4.17%
[DCF] Terminal Value 73.24% ; FCFF base≈28.8b ; Y1≈29.2b ; Y5≈31.6b
[DCF] Fair Price = 276.4 (EV 439b - Net Debt -21.2b = Equity 460b / Shares 1.67b; r=9.03% [WACC]; 5y FCF grow 1.22% → 2.50% )
EPS Correlation: 7.98 | EPS CAGR: 0.87% | SUE: -0.30 | # QB: 0
Revenue Correlation: 4.87 | Revenue CAGR: 1.32% | SUE: 0.34 | # QB: 0
EPS current Quarter (2026-06-30): EPS=1.08 | Chg30d=-0.48% | Revisions=-58% | Analysts=12
EPS next Quarter (2026-09-30): EPS=1.18 | Chg30d=+0.77% | Revisions=-55% | Analysts=8
EPS current Year (2026-12-31): EPS=4.46 | Chg30d=-0.23% | Revisions=-64% | GrowthEPS=+6.0% | GrowthRev=-18.3%
EPS next Year (2027-12-31): EPS=4.92 | Chg30d=-0.38% | Revisions=-55% | GrowthEPS=+10.1% | GrowthRev=+5.5%
[Analyst] Revisions Ratio: -72% (up=4, down=32)